Recent Articles from GlobeNewswire

Former TradingView CEO Oleg Mukhanov joins as President & COO; former TradeStation Group CEO Salomon Sredni appointed Chairman

Garching / Munich, July 7, 2026 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the publication of its primary result analysis of the Phase 3 COMPETE trial in The Lancet. The clinical data demonstrated that non-carrier-added (n.c.a.) 177Lu-edotreotide (also known as 177Lu-edotreotide or ITM-11) significantly improved progression-free survival (PFS) compared to everolimus in patients with Grade 1 or Grade 2 somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).The publication, titled “[177Lu] Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial,” appeared online on July 2, 2026, and can be accessed via the following link: doi.org/10.1016/S0140-6736(26)00604-5.“COMPETE provides the first high-level evidence directly comparing peptide receptor radionuclide therapy (PRRT) with everolimus, a commonly used systemic standard-of-care therapy, in the treatment of advanced GEP-NETs,” said Jaume Capdevila, MD, PhD, last author, study investigator and senior medical oncologist at Vall d'Hebron University Hospital, Barcelona. “The efficacy and safety results observed with 177Lu-edotreotide support its consideration as a potential treatment option for appropriate patients, including those whose disease has progressed following somatostatin analog (SSA) therapy.”“Publication of these data in a peer-reviewed journal underscores the scientific importance of the COMPETE study and provides an important forum for dissemination of the results,” added Thomas Walter, MD, PhD, first author, study investigator and professor of gastroenterology, Hospices Civil of Lyon, France. “These findings offer additional insights into PRRT and support 177Lu-edotreotide as a potential therapeutic option in advanced GEP-NETs, where a high unmet need remains.”COMPETE Trial ResultsThe randomized, open-label Phase 3 COMPETE trial evaluated n.c.a. 177Lu-edotreotide versus everolimus in 309 patients with advanced, progressive, Grade 1 or Grade 2 SSTR-positive GEP-NETs across 49 global sites. Patients were randomized 2:1 to receive 177Lu-edotreotide every three months for up to four cycles or everolimus daily for up to 30 months. Patients were not required but permitted to receive SSAs at the investigator’s discretion for symptom control only. Overall, 21% of patients received concomitant SSA treatment during the study, with similar proportions receiving SSAs in each treatment arm. Top line results of the trial were initially presented at ENETS 2025 and ESMO 2025.Key findings from the COMPETE trial include:

Progress on share buyback programme

Advancing Community New Energy Mobility across China with a Scalable, Long-Term Operating Model

London, July 07, 2026 (GLOBE NEWSWIRE) -- KAR Electrical Power Plant Production Trading FZE (“KEPPT”) has engaged J.P. Morgan to arrange development financing for a landmark $1.6 billion urea plant in Basra, Iraq. The agreement marks a milestone for KEPPT and Iraq’s industrial and economic development. KEPPT will work with the bank to progress financing for the project in conjunction with several leading Export Credit Agencies.

CARLSBAD, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ: SEV), a solar mobility company advancing ultra-efficient transportation, today announced that it has received a Certificate of Conformity (CoC) from the U.S. Environmental Protection Agency (EPA), issued on June 18, 2026, for its 2026 Aptera Launch Edition vehicle, marking an important federal emissions compliance milestone as Aptera continues work toward satisfying remaining applicable requirements for commercialization in the United States.

CAMBRIDGE, United Kingdom, July 07, 2026 (GLOBE NEWSWIRE) -- AMI, a global leader in dynamic firmware for worldwide computing, has officially joined the OpenTitan® project. Hosted by lowRISC® C.I.C., OpenTitan® is the world’s most active and widely adopted open-source silicon project. This partnership unites AMI's decades of firmware security expertise with OpenTitan's transparent, high-quality silicon architecture to deliver unprecedented resilience for critical computing infrastructure.

EBC Financial Group launches the EBC App, a mobile-first account management platform designed to give traders seamless access to multi-account management, fund transfers, copy trading, market updates, and 24/7 multilingual support

Swiss synthetic ice manufacturer presented independent Fraunhofer Institute research to international federation leadership and Member delegates

DALLAS, July 07, 2026 (GLOBE NEWSWIRE) -- Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its second quarter 2026 results:

The following is an update to the second quarter 2026 outlook and gives an overview of our current expectations for the second quarter. Outlooks presented may vary from the actual second quarter 2026 results and are subject to finalisation of those results, which are scheduled to be published on July 30, 2026. Unless otherwise indicated, all outlook statements exclude identified items. 

VertiGIS Neo’s AI-driven capabilities will be showcased at the Esri User Conference, July 13-17 in San Diego

BASINGSTOKE, United Kingdom, July 07, 2026 (GLOBE NEWSWIRE) -- A new study by global tech strategists Juniper Research has revealed that the number of network-tokenised transactions worldwide will increase by a compound annual growth rate of 18.1% over the next five years. The report pinpointed that network tokenisation’s success stems from how it combats fraud; reducing the value of stolen data, and narrowing points at which live card credentials are exposed.

        

Paris, July 07, 2026 (GLOBE NEWSWIRE) -- Cyllene Therapeutics, formerly known as EG 427, today announced the successful closing of a €33 million Series C financing led by new investors GordonMD Global Investments® LP (“GordonMD”) and M Ventures. Existing investors including Andera Partners SAS, Bpifrance Investissement through its InnoBio 3 Fund, L.P. and Lamond Ventures LLC also participated in the round.

VALLOUREC OBTAINS GLOBAL STEEL CLIMATE COUNCIL CERTIFICATION FOR ITS DECARBONIZATION PATHWAY 

As part of its Greening America’s Cities program, new projects will come to Allentown, Pa., Atlanta, Cleveland, Indianapolis, Little Rock, Ark., Los Angeles, Salt Lake City, and Sioux Falls, S.D. This investment showcases how local communities, non-profits, governments and philanthropies can come together to create urban green space nationwide.

Kayan Project, Veea Inc. and Panoptes PBC turn AI into humanity’s force multiplier for the preservation of natural environments and sustainable communities

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- On June 30, 2026, the launch ceremony and New York Forum for OUR WATER Season 3 were held at Bloomberg Headquarters in New York. This event, themed "Rivers of Opportunities", focused on the shared certainties of Shanghai and NYC, anchoring growth through open cooperation and reshaping the future through innovation and resilience.

Analyst Conference Call – 8:00 a.m. Pacific, Friday, August 7, 2026

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ:UNCY) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.

NEW YORK, NY, July 06, 2026 (GLOBE NEWSWIRE) -- Bleichroeder Acquisition Corp. III (the “Company”) announced today the pricing of its initial public offering of 30,000,000 units. The units are expected to be listed on The Nasdaq Stock Global Market (“Nasdaq”) and begin trading tomorrow, July 7, 2026, under the ticker symbol “BCCQU.” Each unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BCCQ” and “BCCQW,” respectively. The offering is expected to close on July 8, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

General Fusion expected to become the first publicly traded, pure-play fusion company

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of MercadoLibre, Inc. (“MercadoLibre” or the “Company”) (NASDAQ:MELI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

THE WOODLANDS, Texas, July 06, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 496 homes in June 2026, including 29 currently or previously leased single-family rental homes. This represents an 8.5% increase compared to 457 homes closed in June 2025. Additionally, the Company closed 1,440 homes during the second quarter of 2026, including 75 currently or previously leased single-family rental homes. This represents an 8.8% increase compared to 1,323 homes closed in the second quarter of 2025.

VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) announces it has sold an aggregate of 8,713,000 common shares (the “Versamet Shares”) of Versamet Royalties Corporation (“Versamet”) pursuant to an agreement with National Bank Financial Inc. by way of a block trade (the “Disposition”) for aggregate gross proceeds of C$130 million.

WASHINGTON, D.C., July 06, 2026 (GLOBE NEWSWIRE) -- The United States Mint (Mint) at Philadelphia struck 250 2.5-ounce silver Semiquincentennial 2026 Declaration of Independence quarters on the Fourth of July under the authority at 31 U.S.C. 5112(u), which authorizes the minting and issuing of silver fractional coins with designs for the Semiquincentennial quarters and half dollar in sizes, weights, fineness, and denominations, and with inscriptions, that the Secretary of the Treasury determines to be appropriate. Bearing no mint mark and featuring a special "July 4" privy mark, these unique quarters were struck sequentially and edge-numbered from 1 through 250.

IRVINE, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Syntiant Corp. (“Syntiant”) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock.

PHILADELPHIA, PA, July 06, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies ("Exyn" or the "Company") (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced financial results for the first quarter ended March 31, 2026.

– Extends and Expands Aggregate Unsecured Credit Facilities to $615 Million –

ENGLEWOOD, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release second quarter 2026 earnings results on Tuesday, August 4, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 5, 2026, at 10:00 a.m. ET.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Tennant Company (NYSE: TNC) (“Tennant” or the “Company”) for potential violations of the federal securities laws.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Mercer International (NASDAQ: MERC) will release its second quarter results for the period ending June 30, 2026 on Thursday, August 6, 2026, after the close of the market. Juan Carlos Bueno, President and Chief Executive Officer and Richard Short, Chief Financial Officer and Secretary, will be hosting a conference call on Friday, August 7, 2026, at 10:00 am ET to discuss the results.

AMF Regulated InformationChâtillon, France, July 6, 2026

MIAMI, July 06, 2026 (GLOBE NEWSWIRE) -- USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended June 30, 2026 after the market closes on Thursday, July 23, 2026.

RIDGELAND, Miss., July 06, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (Nasdaq: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced it will report results for its fourth quarter and fiscal year 2026 at approximately 6:00 a.m. ET on Wednesday, July 22, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases.

WALTHAM, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2026, the company granted non-qualified stock options to purchase 107,060 shares of its common stock to three new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.

TORONTO, July 06, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS) will release its second quarter 2026 financial results after market close on Monday, July 27, 2026, and will host a conference call at 8:00am ET on Tuesday, July 28, 2026.

ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs).

ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the company’s strategic collaboration with Alcon to develop and commercialize light-adjustable Presbyopia-Correcting Intraocular Lenses.

BATON ROUGE, La., July 06, 2026 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) will release its second quarter ended June 30, 2026 earnings report before the market opens on Thursday, August 6, 2026. Lamar will host a conference call on Thursday, August 6, 2026 at 8:00 a.m. (Central time) to discuss the Company’s results and answer questions relating to company operations.

SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its second quarter 2026 earnings in a press release to be issued after the market closes on Tuesday, July 28, 2026.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating York Space Systems, Inc. (NYSE: YSS) (“York Space” or the “Company”) for potential violations of the federal securities laws.

MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that it has engaged the services of Independent Trading Group ("ITG") to provide market-making services in accordance with Canadian Securities Exchange (“CSE”) policies and applicable securities laws.

PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russell 2000® and the broad-market Russell 3000® Indexes, effective at the close of U.S. equity markets on June 26, 2026.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the federal securities laws.

Breakthrough Therapy Designation granted for pevifoscorvir sodium in China

Abivax Announces Closing of $920 Million Public Offering

BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the closing of its previously announced registered direct offering (the “Offering”) pursuant to a definitive securities purchase agreement led by two new fundamental institutional investors with participation from a large existing shareholder for the purchase of an aggregate of 4,380,313 shares of its common stock. The gross proceeds to the Company were approximately $15 million, before deducting placement agents’ fees and other Offering expenses. Elicio intends to use the net proceeds from the Offering, together with its existing cash, cash equivalents and marketable securities, to primarily fund the planned Phase 1 clinical development of ELI-002 7P in metastatic PDAC and Elicio’s pipeline and platform, as well as for working capital and general corporate purposes.

SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the second quarter 2026 on Wednesday, August 5, 2026, after the market closes. The Company will also host a conference call and slide presentation the same day at 2:00 p.m. Pacific / 5:00 p.m. Eastern time with Ashish Masih, President and Chief Executive Officer, Tomas Hernanz, Executive Vice President and Chief Financial Officer, and Bruce Thomas, Vice President, Global Investor Relations, presenting and discussing the reported results.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its second quarter 2026 earnings before the market opens on Thursday, July 23, 2026.

CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (NASDAQ: SPT), a leading AI-powered Social Intelligence Platform, today announced that it will report its financial results for the second quarter ending June 30, 2026 after market close on Thursday, August 6, 2026.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it will report results for the quarter ended June 30, 2026, prior to the opening of the Nasdaq Global Select Market on Thursday, August 6, 2026.

PERTH, Australia, July 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Globavend Holdings Limited (NASDAQ: GVH) (“Globavend” or the “Company”), an emerging e-commerce logistics provider and AI-powered digital entertainment company, today announced that all of its outstanding Series A Warrants have expired in accordance with their terms, further simplifying the Company’s capital structure.

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) --  21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced that the Board of Trustees of Listed Funds Trust has approved a 1-for-10 reverse share split for the 21Shares 2x Long Sui ETF (Ticker: TXXS).

York, PA, July 06, 2026 (GLOBE NEWSWIRE) -- WellSpan Health and Cancer Care Associates of York (CCAY) today marked the official start of their integrated operating arrangement, bringing together two trusted organizations to deliver a more connected, patient-centered cancer care experience across York County and the broader region.

WASHINGTON, D.C., July 06, 2026 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will release the Best of the Mint 1916 Standing Liberty Quarter Dollar Gold Coin and Silver Medal Set —the second of five numismatic gold coin and companion silver medal sets celebrating the Mint’s special journey through history—on July 10, 2026, at noon EDT. Orders are limited to one set per household until Monday, July 13 at noon.   

FLORENCE, Italy, July 06, 2026 (GLOBE NEWSWIRE) -- The infectious energy of Bebe Vio, the understated elegance of Gianfranco Zola, the remarkable 33 beats per minute of Gregorio Paltrinieri's heart, Prince Diego Milito's Calabrian roots, and the quiet confidence of a newly married Armand Duplantis, all brought together by a Federico Buffa at his brilliant best, generously sharing captivating stories from the history of sport, from black cats to open waters. These were just some of the memorable snapshots from the stage of Florence's Teatro del Maggio Musicale Fiorentino, which hosted the 30th edition of the Fair Play Menarini International Award.

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Microsoft (MSFT) To Contact Them Directly To Discuss Their Options

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Meridian3 Industrials Acquisition Corp (the “Company”), a special purpose acquisition company formed for the purpose of entering into a business combination with one or more businesses or entities, today announced the successful closing of its initial public offering of 20,125,000 units which includes 2,625,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $201,250,000. The units began trading under the ticker symbol "MIACU" on The Nasdaq Global Market, or Nasdaq on July 2, 2026. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “MIAC” and “MIACW,” respectively.

If you sold common stock of ChampionX between February 29, 2024 and April 1, 2024 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Market participants can begin preparing today for the launch of a historic new U.S. exchange

Boston, MA, July 06, 2026 (GLOBE NEWSWIRE) -- Ampersand Capital Partners today announced that Melanie Fan, Partner, has been named to GrowthCap’s Top Women Leaders in Growth Investing of 2026.This annual recognition honors a select group of professionals who have distinguished themselves through notable performance in their respective roles and meaningful contributions to the growth investing industry.

MELBOURNE, Ark., July 06, 2026 (GLOBE NEWSWIRE) -- Oobotic, an advanced manufacturing company, has established its first production facility in Melbourne, Arkansas. The company plans to invest approximately $6.5 million in the facility and create up to 70 jobs over the next four years.

CHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately $0.2229 per share, continuing the buyback activity carried out under its ongoing repurchase program.

If you purchased or acquired Graphic Packaging securities between February 4, 2025 and February 2, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

If you purchased or acquired FS KKR Capital securities between May 8, 2024 and February 25, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

TORONTO, July 06, 2026 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX & NASDAQ: CIGI) (“Colliers” or the “Company”) today announced that results for the second quarter ended June 30, 2026, will be issued by press release on July 30, 2026, at approximately 7:00am ET.